The Petri Dish: Cyteir puts a drug on pause, Alexion vet joins Watertown biotech

The Petri Dish is a roundup of news that may get otherwise overlooked amid the influx of health care happenings. This week: Cyteir pauses development of cancer drug, Pfizer vet joins Watertown biotech and CEO steps down from Evelo Biosciences.

Top of the List: Central Ohio’s largest fee and commission financial planners—and what does that mean, anyway?

Three questions with the CEO: MaieB Hospitality wants a bigger presence in Austin

Clearview FCU to open 3 new financial centers

Who were Wall Street’s biggest dealmakers of 2018? Here’s the tally.

End of key tax break could spell doom — and surprise bills — for some businesses

Carlisle proposes $500M-$700M Mid-City mixed-use at former Racquet Club

Queen City Hills plans massive development anchored by labs in Avondale

Million Dollar Monday: Crestline home on the market for $2.295M

The Petri Dish: Cyteir puts a drug on pause, Alexion vet joins Watertown biotech

Previous Tampa property insurer plans more business in Florida despite market turmoil

Next South Grand's City Diner has closed

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Bridgeworks high-rise gets bond approval from Port of Cleveland

Hoover commission recommends new strip retail center for U.S. 31

Triad Healthcare Network receives $13.2 million for reducing patient Medicare costs

Using the arts to inspire the Cincinnati region’s kids

Here’s something Phoenix hasn’t heard in a while: Home prices show signs of stability

Bridgeton cup and container manufacturers file bankruptcy

MENU

FirstStar Group

More Stories

Here’s who’s behind Cincinnati law firm’s explosive investment advisory growth